Table 2. Two-way ANOVA test of the immunolabelling densities (gold grains/µm2) of polymerase II, snRNPs, hnRNPs and CStF in myoblast nucleoplasm: factor Dystrophy (healthy and DM2), factor Cell senescing in vitro (early and late passage), and interaction term (Dystrophy - Cell senescing in vitro).
Polymerase II | |
---|---|
Dystrophy | P<0.001 |
Cell senescing in vitro | P<0.001 |
Interaction term | P=0.001 |
hnRNPs | |
---|---|
Dystrophy | P<0.001 |
Cell senescing in vitro | P=0.002 |
Interaction term | P<0.043 |
snRNPs | |
---|---|
Dystrophy | P<0.001 |
Cell senescing in vitro | P<0.001 |
Interaction term | P<0.001 |
CStF | |
---|---|
Dystrophy | P<0.001 |
Cell senescing in vitro | P=0.027 |
Interaction term | P=0.017 |